Irritable Bowel Syndrome News and Research

Latest Irritable Bowel Syndrome News and Research

European patent strengthens Soligenix' topically active steroid intellectual property portfolio

European patent strengthens Soligenix' topically active steroid intellectual property portfolio

Lexicon Pharmaceuticals first-quarter revenues down 61%

Lexicon Pharmaceuticals first-quarter revenues down 61%

Positive results from Phase 2 clinical study of LX1031 in IBS patients presented at DDW 2010

Positive results from Phase 2 clinical study of LX1031 in IBS patients presented at DDW 2010

Targeted antibiotics provide safe, long-lasting improvement for IBS patients, says study

Targeted antibiotics provide safe, long-lasting improvement for IBS patients, says study

Mayo Clinic researchers identify genetic variants in serotonin genes that impact IBS

Mayo Clinic researchers identify genetic variants in serotonin genes that impact IBS

Ocera Therapeutics presents Phase 2 proof-of-concept study results of AST-120 in non-constipating IBS

Ocera Therapeutics presents Phase 2 proof-of-concept study results of AST-120 in non-constipating IBS

Doctors often treat IBS patients with narcotics: Researchers

Doctors often treat IBS patients with narcotics: Researchers

Sucampo Pharmaceuticals presents Phase 2 cobiprostone clinical trial data at DDW 2010

Sucampo Pharmaceuticals presents Phase 2 cobiprostone clinical trial data at DDW 2010

NIAID researchers initiate trial of DAS181 in patients with asthma, bronchiectasis

NIAID researchers initiate trial of DAS181 in patients with asthma, bronchiectasis

Albireo to present study results of A3309 in patients with chronic constipation at 2010 DDW annual meeting

Albireo to present study results of A3309 in patients with chronic constipation at 2010 DDW annual meeting

Neurocrine Biosciences reports net loss of $8.6M in first quarter 2010

Neurocrine Biosciences reports net loss of $8.6M in first quarter 2010

FDHN announces 2010 AGA Research Scholars

FDHN announces 2010 AGA Research Scholars

Lexicon Pharmaceuticals to present Phase 2 study results of LX1031 for non-constipating IBS at DDW 2010

Lexicon Pharmaceuticals to present Phase 2 study results of LX1031 for non-constipating IBS at DDW 2010

IBS patients treated with cognitive behavior therapy have positive response: Study

IBS patients treated with cognitive behavior therapy have positive response: Study

Napo Pharmaceuticals announces formation of Finder's Agreement with Luye Pharma Group

Napo Pharmaceuticals announces formation of Finder's Agreement with Luye Pharma Group

DDW2010 Investor Event to provide update on TARGET 1 and TARGET 2 Phase 3 trials

DDW2010 Investor Event to provide update on TARGET 1 and TARGET 2 Phase 3 trials

Homeopathy – Is it a safer and effective alternative?

Homeopathy – Is it a safer and effective alternative?

Research roundup: Revamping NCI Clinical Trials, reducing malpractice suits, health disparities persist

Research roundup: Revamping NCI Clinical Trials, reducing malpractice suits, health disparities persist

Ocera Therapeutics presents data on prevalence of neurocognitive impairment in cirrhotic patients

Ocera Therapeutics presents data on prevalence of neurocognitive impairment in cirrhotic patients

S. thermophilus CRL 1190-fermented milk effective in therapeutic treatment of chronic gastritis: Research

S. thermophilus CRL 1190-fermented milk effective in therapeutic treatment of chronic gastritis: Research